“The best way to move the world forward is by trusting innovative new ideas.” (Edgar E. Schein)
We provide our disruptive technology solutions at the highest level of technology and medical expertise and in absolute compliance with ethical and regulatory standards. We are dedicated to use our know-how to improve the fate and the quality of life of people suffering from chronic and acute diseases worldwide.
Dr. Alexander Kaya
Dr. Alexander Kaya is CEO and co-founder of cantiMED. As an entrepreneur Alexander has more than 17 years’ experience in business development and corporate management. In business development his breadth of knowledge and experience spans a variety in life science and medical technology, including biophysical and biomedical engineering topics and semiconductor metrology.
Alexander is the inventor of the FEBID (Focused Electron Beam Induced Deposition) based Nano3DSense™ Technology for the 3D nanoprinting of ultra-sized nano-sensors beyond the 10 nanometer scale. He holds a PhD in physics from Johann Wolfgang Goethe-University Frankfurt am Main and numerous patents in nano-structuring techniques for semiconductor and microsystems applications.
Alexander is also a pioneer in the market development and commercialization of direct-writing (“bottom-up”) techniques with focused electron and ion beams. Prior to Nanoss GmbH, from 1999-2005, Alexander was the CTO and head of system integration of the mask repair division at Carl Zeiss SMS (former NaWoTec GmbH) which he co-founded in 1999 as a spin-off from Deutsche Telekom AG Research Center. This earned him several renowned awards (e.g. “Innovationspreis der Deutschen Wirtschaft, Bester Start-Up” (“The German Industry Innovation Award, Best Start-Up”) in 2003).